undamentalytics Newsletter

Schmid John P.: insider trades

Director at 3 companies we cover. 4 open-market purchases and 1 sale not made under a pre-set plan, reported from March 25, 2024 to April 1, 2026.

Would copying Schmid John P.’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Schmid John P.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 1 +47.2% +47.2% 0% 1 — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Xeris Biopharma Holdings, Inc. XERS —30May 10, 2024August 13, 2024
Design Therapeutics, Inc. DSGN —10March 25, 2024March 25, 2024
Anaptysbio, Inc ANAB —01April 1, 2026April 1, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
April 1, 2026March 30, 2026 ANAB Sale $1,158,467 +47.2%not yetnot yet
August 13, 2024August 12, 2024 XERS Purchase $10,159 not yetnot yetnot yet
August 12, 2024August 9, 2024 XERS Purchase $10,155 not yetnot yetnot yet
May 10, 2024May 10, 2024 XERS Purchase $10,314 not yetnot yetnot yet
March 25, 2024March 22, 2024 DSGN Purchase $99,750 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Schmid John P. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.